Kura Oncology, Inc. (KURA)
9.08
-0.62
(-6.39%)
USD |
NASDAQ |
Oct 16, 16:00
9.12
+0.04
(+0.44%)
After-Hours: 20:00
Kura Oncology Net Income (TTM) : -296.78M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -296.78M |
| March 31, 2026 | -294.57M |
| December 31, 2025 | -278.67M |
| September 30, 2025 | -216.88M |
| June 30, 2025 | -197.17M |
| March 31, 2025 | -181.89M |
| December 31, 2024 | -173.98M |
| September 30, 2024 | -197.55M |
| June 30, 2024 | -181.75M |
| March 31, 2024 | -168.09M |
| December 31, 2023 | -152.63M |
| September 30, 2023 | -142.96M |
| June 30, 2023 | -139.86M |
| March 31, 2023 | -137.46M |
| December 31, 2022 | -135.84M |
| September 30, 2022 | -135.47M |
| June 30, 2022 | -133.33M |
| March 31, 2022 | -132.22M |
| December 31, 2021 | -130.47M |
| September 30, 2021 | -123.88M |
| June 30, 2021 | -114.28M |
| March 31, 2021 | -101.11M |
| Date | Value |
|---|---|
| December 31, 2020 | -89.62M |
| September 30, 2020 | -81.33M |
| June 30, 2020 | -73.95M |
| March 31, 2020 | -68.41M |
| December 31, 2019 | -63.14M |
| September 30, 2019 | -61.37M |
| June 30, 2019 | -59.99M |
| March 31, 2019 | -59.78M |
| December 31, 2018 | -60.45M |
| September 30, 2018 | -55.10M |
| June 30, 2018 | -49.42M |
| March 31, 2018 | -42.50M |
| December 31, 2017 | -35.43M |
| September 30, 2017 | -32.03M |
| June 30, 2017 | -29.63M |
| March 31, 2017 | -28.47M |
| December 31, 2016 | -27.56M |
| September 30, 2016 | -26.69M |
| June 30, 2016 | -25.85M |
| March 31, 2016 | -24.78M |
| December 31, 2015 | -22.62M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Inovio Pharmaceuticals, Inc. | -67.43M |
| Fortress Biotech, Inc. | 141.19M |
| Spero Therapeutics, Inc. | 7.383M |
| Gossamer Bio, Inc. | -125.22M |
| ACADIA Pharmaceuticals, Inc. | 380.48M |